References
- Ataman-Önal Y, Munier S, Ganée A, Terrat C, Durand PY, Battail N, Martinon F, Grand RL, Charles MH, Delair T, Verrier B. Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J Control Rel 2006; 112: 175–185
- Bartus RT, Tracy MA, Emerich DF, et al. Sustained delivery of proteins for novel therapeutic agents. Science 1998; 281: 1161–1162
- Bilati U, Alle'mann E, Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm 2005; 59: 375–388
- Chesko J, Kazzaz J, Ugozzoli M, O'Hagan DT, Singh M. An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles. J Pharm Sci 2005; 94: 2510–2519
- Couvreura P, Blanco-Prietoa MJ, Puisieuxa F, Roquesb B, Fattal E. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. Adv Drug Delivery Rev 1997; 28: 85–96
- Cui ZR, Mumper RJ. Coating of cationized protein on engineered nanoparticles results in enhanced immune responses. Int J Pharm 2002; 238: 229–239
- Fu K, Klibanov AM, Langer R. Protein stability in controlled-release systems. Nat Biotechnol 2000; 18: 24–25
- Hongkee S. Protein behavior at the water/methylene chloride interface. J Pharm Sci 1999; 88: 1320–1325
- Hrkach JS, Peracchia MT, Domb A, Lotan N, Langer R. Nanotechnology for biomaterials engineering: Structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy. Biomaterials 1997; 18: 27–34
- Huang MJ, Gou ML, Qian ZY, Dai M, Li XY, Huang AL, Wei YQ. One-step preparation of poly(e-caprolactone)-poly(ethylene glycol)-poly(e-caprolactone) nanoparticles for plasmid DNA delivery. J Biomed Mater Res, Part A, In press
- Jung T, Kamm W, Breitenbach A, Hungerer KD, Hundt E, Kissel T. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-clycolide): Evaluation of antibody response after oral and nasal application in mice. Pharm Res 2001; 18: 352–360
- Kazzaz J, Neidleman J, Singh M, Ott G, O'Hagan DT. Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J Control Rel 2000; 67: 347–356
- Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976; 263: 797–800
- Liu JY, Wei YQ, Yang L, Zhao X, Tian L, Hou JM, Ting N, et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 2003; 102: 1815–1823
- Moein Moghimi S, Christy Hunter A, Murray JC. Nanomedicine: Current status and future prospects. FASEB J 2005; 19: 311–330
- Nimesh S, Goyal A, Pawar V, Jayaraman S, Kumar P, Chandra R, Singh Y, Gupta KC. Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells. J Control Rel 2006; 110: 457–468
- O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Delivery Rev 1997; 28: 25–42
- Piao L, Dai ZL, Deng MX, Chen XS, Jing XB. Synthesis and characterization of PCL/PEG/PCL triblock copolymers by using calcium catalyst. Polymer 2003; 44: 2025–2031
- Plum SM, Holaday JW, Ruiz A, Madsen JW, Fogler WE, Fortier AH. Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development. Vaccine 2000; 19: 1294–1303
- Shakesheff KM, Evora C, Soriano I, Langer R. The adsorption of poly(vinyl alcohol) to biodegradable microparticles studied by X-ray photoelectron spectroscopy (XPS). J Colloid Interface Sci 1997; 185: 538–547
- Singh M, O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 1999; 17: 1075–1081
- Singh M, Briones M, Ott G, O'Hagan DT. Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 2000; 97: 811–816
- Wei YQ, Huang MJ, Yang L, Zhao X, Tian L, et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA 2001, 98: 11545–11550
- Weich HA, Iberg N, Klagsbrun M, Folkman J. Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells. Growth Factors 1990; 2: 313–320